Either, deletion of Siah2 or pharmacological blockade of 26S proteasome (a major pathway of Nrf2 degradation, [28,29]) by MG132 restored hypoglycemia-induced Nrf2 function and BBB integrity (see Figs 3 and 4). The gene discussed is NFE2L2; the disease is Hypoglycemia.